Next generation deep sequencing and vaccine design: Today and tomorrow

Trends in Biotechnology

Volumn 30, Issue 9, 2012, Pages 443-452

  Luciani, Fabio ^a   Bull, Rowena A ^a   Lloyd, Andrew R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEX DYNAMICS; DATA SETS; HOST RESPONSE; INFECTIOUS DISEASE; MODUS OPERANDI; SHORT TIME SCALE; VACCINE DEVELOPMENT;

DATA PROCESSING; MICROBIOLOGY; PATHOGENS; RESEARCH; VIRUSES;

VACCINES;

HLA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; NEUTRALIZING ANTIBODY; T LYMPHOCYTE RECEPTOR; VACCINE;

ADAPTIVE IMMUNITY; ANALYTICAL PARAMETERS; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA MODIFICATION; DRUG DESIGN; DRUG SAFETY; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HISTONE MODIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MENINGITIS; MENINGOCOCCEMIA; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIA; TRANSCRIPTOMICS; VIRUS STRAIN;

ANIMALS; COMMUNICABLE DISEASE CONTROL; COMPUTATIONAL BIOLOGY; DRUG DESIGN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SEQUENCE ANALYSIS, DNA; VACCINES;

EID: 84865192980     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.05.005     Document Type: Review

References (80)

1. Rappuoli R., et al. Medicine. The intangible value of vaccination. Science 2002, 297:937-939.
2. Picker L.J., et al. New paradigms for HIV/AIDS vaccine development. Annu. Rev. Med. 2012, 63:95-111.
3. Zimmer S.M., Burke D.S. Historical perspective-emergence of influenza A (H1N1) viruses. N. Engl. J. Med. 2009, 361:279-285.
4. Metzker M.L. Sequencing technologies - the next generation. Nat. Rev. Genet. 2010, 11:31-46.
5. Schadt E.E., et al. A window into third-generation sequencing. Hum. Mol. Genet. 2010, 19:R227-R240.
6. Ley T.J., et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72.
7. Margeridon-Thermet S., et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J. Infect. Dis. 2009, 199:1275-1285.
8. Ozsolak F., Milos P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 2010, 12:87-98.
9. Birzele F., et al. Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human. Nucleic Acids Res. 2011, 39:7946-7960.
10. Burwitz B.J., et al. Simian immunodeficiency virus SIVmac239 nef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost tegimen in rhesus macaques. J. Virol. 2011, 85:3683-3689.
11. Wu X., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011, 333:1593-1602.
12. Gonzaga-Jauregui C., et al. Human genome sequencing in health and disease. Annu. Rev. Med. 2012, 63:35-61.
13. Gilbert J.A., Dupont C.L. Microbial metagenomics: beyond the genome. Ann. Rev. Mar. Sci. 2011, 3:347-371.
14. Xu B., et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011, 7:e1002369.
15. Meyerson M., et al. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 2010, 11:685-696.
16. Altshuler D.M., et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467:52-58.
17. Stephens P.J., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
18. Poland G.A., et al. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. PLoS Pathog. 2011, 7:e1002344.
19. Wegner K.M. Massive parallel MHC genotyping: titanium that shines. Mol. Ecol. 2009, 18:1818-1820.
20. Sultan M., et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321:956-960.
21. Gatherer D., et al. High-resolution human cytomegalovirus transcriptome. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19755-19760.
22. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
23. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 2010, 64:123-141.
24. Bernstein B.E., et al. The mammalian epigenome. Cell 2007, 128:669-681.
25. Lister R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
26. Robertson G., et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 2007, 4:651-657.
27. Northrup D.L., Zhao K. Application of ChIP-Seq and related techniques to the study of immune function. Immunity 2011, 34:830-842.
28. Rappuoli R. From Pasteur to genomics: progress and challenges in infectious diseases. Nat. Med. 2004, 10:1177-1185.
29. Rappuoli R., Del Giudice G. Identification of vaccine targets. Vaccines: From Concept to Clinic 1999, 1-17. CRC Press. L.C. Paoletti, P.M. McInnes (Eds.).
30. Poland G.A. Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin. Pharmacol. Ther. 2007, 82:623-626.
31. Fleischmann R.D., et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995, 269:496-512.
32. Gossger N., et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012, 307:573-582.
33. Sette A., Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010, 33:530-541.
34. Rappuoli R., et al. Vaccine discovery and translation of new vaccine technology. Lancet 2011, 378:360-368.
35. Croucher N.J., et al. Rapid pneumococcal evolution in response to clinical interventions. Science 2011, 331:430-434.
36. Harris S.R., et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
37. Sharma C.M., et al. The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 2010, 464:250-255.
38. Rolland M., et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat. Med. 2011, 17:366-371.
39. Lefebvre G., et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J. Virol. 2011, 85:6205-6211.
40. Woodhouse S.D., et al. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 2010, 52:443-453.
41. Amit I., et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 2009, 326:257-263.
42. Miconnet I. Probing the T-cell receptor repertoire with deep sequencing. Curr. Opin. HIV AIDS 2012, 7:64-70.
43. Sherwood A.M., et al. Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T Cell Commitment. Sci. Transl. Med. 2011, 3:90ra61.
44. Warren R.L., et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res. 2011, 21:790-797.
45. Boyd S.D., et al. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J. Immunol. 2010, 184:6986-6992.
46. Bull R.A., et al. Contribution of intra- and inter-host dynamics to norovirus evolution. J. Virol. 2012, 86:3219-3229.
47. Bull R.A., et al. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog. 2011, 7:e1002243.
48. Fischer W., et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS ONE 2010, 5:e12303.
49. Ghedin E., et al. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J. Infect. Dis. 2011, 203:168-174.
50. Fischer W., et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 2007, 13:100-106.
51. Barr I.G., et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010, 28:1156-1167.
52. Onions D., et al. Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome. Vaccine 2011, 29:7117-7121.
53. Neverov A., Chumakov K. Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20063-20068.
54. Victoria J.G., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84:6033-6040.
55. Beerenwinkel N. Ultra-deep sequencing for the analysis of viral populations. Curr. Opin. Virol. 2011, 1:413-418.
56. Bendall S.C., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
57. Ojosnegros S., Beerenwinkel N. Models of RNA virus evolution and their roles in vaccine design. Immunome Res. 2010, 6(Suppl. 2):S5.
58. Lo C., et al. Strobe sequence design for haplotype assembly. BMC Bioinform. 2011, 12(Suppl. 1):S24.
59. Kampmann M.L., et al. A simple method for the parallel deep sequencing of full influenza A genomes. J. Virol. Methods 2011, 178:243-248.
60. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
61. Liao H.X., et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 2011, 208:2237-2249.
62. Chang S.T., et al. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. MBio 2011, 2:e00134-e00211.
63. Long Hoang T., et al. Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. J. Infect. Dis. 2009, 199:537-546.
64. Fehniger T.A., et al. Next-generation sequencing identifies the natural killer cell microRNA transcriptome. Genome Res. 2010, 20:1590-1604.
65. Schopman N.C.T., et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 2012, 40:414-427.
66. Yang Z., et al. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11513-11518.
67. Zhao H., et al. The transcriptome of the adenovirus infected cell. Virology 2012, 424:1-14.
68. Ball M.P., et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 2009, 27:361-368.
69. Bimber B.N., et al. Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J. Virol. 2010, 84:12087-12092.
70. Tsibris A.M., et al. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS ONE 2009, 4:e5683.
71. Eckerle L.D., et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010, 6:e1000896.
72. Cordey S., et al. Rhinovirus genome evolution during experimental human infection. PLoS ONE 2010, 5:e10588.
73. Solmone M., et al. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J. Virol. 2009, 83:1718-1726.
74. Verbinnen T., et al. Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing. J. Virol. 2010, 84:11124-11133.
75. Love T.M., et al. Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences. J. Virol. 2010, 84:5802-5814.
76. Nakamura S., et al. Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS ONE 2009, 4:e4219.
77. Greninger A.L., et al. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS ONE 2010, 5:e13381.
78. Cale E.M., et al. Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. J. Virol. 2011, 85:3746-3757.
79. Zagordi O., et al. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 2010, 38:7400-7409.
80. Palacios G., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med. 2008, 358:991-998.